MET and neurofibromatosis: The mesenchymal type shows high expression of chitinase-3-like protein 1 (CHI3L1) and tyrosine-protein kinase Met (c-Met), with neurofibromatosis type 1 (NF1) mutation/deletion or low expression of NF1.